United States Molecular Breast Imaging Market 2031 | Growth Drivers, Key Players & Investment Opportunities

Market Size and Growth

Molecular Breast Imaging Market growing with a High CAGR during the forecast period 2024-2031.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/molecular-breast-imaging-market?sb

Key Development:

United States: Recent Molecular Breast Imaging Developments

✅ In October 2025, researchers at Mayo Clinic reported that adding molecular breast imaging (MBI) to 3D mammograms more than doubled invasive cancer detection in women with dense breast tissue versus mammography alone, highlighting its potential to improve early detection.

✅ In September 2025, findings from the Density MATTERS multicenter trial showed that combining MBI with digital breast tomosynthesis (DBT) significantly increased overall invasive cancer detection in women with dense breasts across five U.S. screening sites, validating supplemental MBI's clinical value.

✅ In October 2025, Applied Radiology and other imaging outlets reported that supplemental MBI continued to enhance cancer detection in dense breasts with improved sensitivity for small, node‐negative tumors, reaffirming robust real‐world clinical performance.

✅ In September 2025, Radiology publications confirmed that MBI's molecular functional imaging using technetium‐99m tracers can reveal cancers masked on mammograms, supporting broader adoption of MBI as a supplemental diagnostic tool in dense breast screening protocols.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=molecular-breast-imaging-market

Japan: Recent Molecular Breast Imaging Developments

✅ In October 2025, Japanese breast imaging research conferences highlighted enhanced supplemental imaging methods, positioning functional techniques like MBI alongside evolving AI‐assisted mammography tools to address limitations in dense breast tissue detection.

✅ In September 2025, healthcare insights in Japan noted expanding interest in advanced imaging modalities, including molecular‐level approaches, to complement regular screening practices reflecting clinical momentum toward better diagnostic precision.

✅ In October 2025, broader Asia‐Pacific diagnostic imaging reports emphasized growth in advanced breast imaging capabilities (e.g., dual‐head detectors, improved radiotracers) that underpin molecular imaging adoption in Japan's major hospitals and cancer centers.

✅ In September 2025, experts cited international studies (e.g., U.S. density trials) in Japanese clinical forums as evidence supporting molecular imaging's value in dense tissue detection, fueling academic and diagnostic interest for localized research applications.

Key Players:

=> CMR Naviscan Corporation, SmartBreast Corporation and DIGIRAD HEALTH, INC. among others.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/molecular-breast-imaging-market?sb

Key Segments:

By Design Type

Radioactive Tracer - ~60% share

Utilizes radioactive isotopes to detect and visualize breast tissue anomalies for diagnostic and screening purposes.

Special Camera - ~40% share

Advanced imaging devices designed to enhance breast imaging quality with higher resolution and reduced radiation exposure.

By Modality

Single Head Gamma Camera - ~35% share

Standard modality for basic breast imaging, offering cost-effective diagnostic capabilities.

Dual Head Camera - ~65% share

Provides higher sensitivity and accuracy for breast diagnosis and screening, widely adopted in advanced healthcare facilities.

By Application

Breast Screening - ~50% share

Early detection of breast cancer in asymptomatic populations through routine diagnostic procedures.

Breast Diagnosis - ~50% share

Detailed imaging for symptomatic patients or follow-up after abnormal screening results, supporting treatment planning.

By End-User

Hospitals - ~40% share

Major adopters for routine breast screening and diagnostic imaging services.

Diagnostic Centers - ~25% share

Specialized facilities providing focused imaging services with advanced modalities.

Specialty Clinics - ~15% share

Clinics dedicated to breast health, often combining imaging with consultation and follow-ups.

Academic and Research Institutes - ~10% share

Use imaging technologies for clinical studies, research, and development of new breast imaging techniques.

Others - ~10% share

Includes private healthcare providers, mobile imaging units, and telemedicine collaborations.

By Region

North America - ~35% share

U.S., Canada, Mexico - High adoption due to established breast cancer screening programs, advanced technology availability, and strong healthcare infrastructure.

Europe - ~25% share

Germany, U.K., France, Italy, Rest of Europe - Mature market with government-led screening initiatives and private diagnostic investments.

Asia-Pacific - ~25% share

China, India, Japan, Australia, Rest of Asia-Pacific - Rapidly growing awareness, expanding healthcare infrastructure, and increasing breast cancer prevalence driving market demand.

Latin America - ~10% share

Brazil, Argentina, Rest of South America - Emerging market with increasing diagnostic center adoption and government initiatives for early detection.

Middle East & Africa - ~5% share

Growing focus on healthcare modernization, early detection programs, and investment in imaging infrastructure.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.